Ivan Nicolas Vial, MD | |
2450 Ne Mary Rose Pl Ste 201, Bend, OR 97701-7133 | |
(541) 317-0808 | |
Not Available |
Full Name | Ivan Nicolas Vial |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2450 Ne Mary Rose Pl Ste 201, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811284433 | NPI | - | NPPES |
500719243 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | MD180009 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ivan Nicolas Vial, MD 2450 Ne Mary Rose Pl, Ste 201, Bend, OR 97701 Ph: () - | Ivan Nicolas Vial, MD 2450 Ne Mary Rose Pl Ste 201, Bend, OR 97701-7133 Ph: (541) 317-0808 |
News Archive
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a special cash dividend of US$1.50 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$156 million. The distribution of the special dividend is conditional upon the approval of the relevant PRC government authorities.
With heroin abuse on the rise in the United States, related surgical complications are also increasing, including severe infections and complications related to heroin injection.
Cyclacel Pharmaceuticals, Inc. announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes refractory to hypomethylating agents, such as azacitidine and decitabine. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
› Verified 5 days ago
Amanda K Nelson, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 777 Sw Mill View Way Ste 100, Bend, OR 97702 Phone: 541-388-1022 | |
Dr. Emily Borsting, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2450 Ne Mary Rose Pl Ste 205, Bend, OR 97701 Phone: 541-316-0627 | |
Dr. Gary Lyle Gallagher, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 777 Sw Mill View Way Ste 250, Bend, OR 97702 Phone: 541-728-3184 | |
Dr. Linda Joann Leffel, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1715 Sw Chandler Avenue, Suite 100, Bend, OR 97702 Phone: 541-388-3006 Fax: 541-382-7605 |